Your browser doesn't support javascript.
loading
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.
Puigdelloses, Montserrat; Garcia-Moure, Marc; Labiano, Sara; Laspidea, Virginia; Gonzalez-Huarriz, Marisol; Zalacain, Marta; Marrodan, Lucia; Martinez-Velez, Naiara; De la Nava, Daniel; Ausejo, Iker; Hervás-Stubbs, Sandra; Herrador, Guillermo; Chen, ZhiHong; Hambardzumyan, Dolores; Patino Garcia, Ana; Jiang, Hong; Gomez-Manzano, Candelaria; Fueyo, Juan; Gállego Pérez-Larraya, Jaime; Alonso, Marta.
Afiliación
  • Puigdelloses M; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.
  • Garcia-Moure M; Programs in Solid Tumors and Neuroscience, Foundation for the Applied Medical Research, Pamplona, Spain.
  • Labiano S; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Laspidea V; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.
  • Gonzalez-Huarriz M; Programs in Solid Tumors and Neuroscience, Foundation for the Applied Medical Research, Pamplona, Spain.
  • Zalacain M; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.
  • Marrodan L; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.
  • Martinez-Velez N; Programs in Solid Tumors and Neuroscience, Foundation for the Applied Medical Research, Pamplona, Spain.
  • De la Nava D; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.
  • Ausejo I; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.
  • Hervás-Stubbs S; Programs in Solid Tumors and Neuroscience, Foundation for the Applied Medical Research, Pamplona, Spain.
  • Herrador G; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.
  • Chen Z; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.
  • Hambardzumyan D; Programs in Solid Tumors and Neuroscience, Foundation for the Applied Medical Research, Pamplona, Spain.
  • Patino Garcia A; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.
  • Jiang H; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.
  • Gomez-Manzano C; Programs in Solid Tumors and Neuroscience, Foundation for the Applied Medical Research, Pamplona, Spain.
  • Fueyo J; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.
  • Gállego Pérez-Larraya J; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain.
  • Alonso M; Programs in Solid Tumors and Neuroscience, Foundation for the Applied Medical Research, Pamplona, Spain.
J Immunother Cancer ; 9(7)2021 07.
Article en En | MEDLINE | ID: mdl-34281988
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glioblastoma / Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral / Antígeno B7-H1 / Inmunidad / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glioblastoma / Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral / Antígeno B7-H1 / Inmunidad / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: España